Ingevity Corporation $NGVT Holdings Decreased by Leeward Investments LLC MA

Leeward Investments LLC MA decreased its holdings in shares of Ingevity Corporation (NYSE:NGVT) by 3.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 174,783 shares of the company’s stock after selling 6,740 shares during the quarter. Leeward Investments LLC MA’s holdings in Ingevity were worth $7,531,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Inspire Investing LLC grew its holdings in shares of Ingevity by 4.1% during the second quarter. Inspire Investing LLC now owns 9,038 shares of the company’s stock valued at $389,000 after buying an additional 358 shares in the last quarter. KLP Kapitalforvaltning AS grew its holdings in shares of Ingevity by 3.4% during the second quarter. KLP Kapitalforvaltning AS now owns 126,500 shares of the company’s stock valued at $5,451,000 after buying an additional 4,200 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Ingevity by 7.7% during the second quarter. State of Alaska Department of Revenue now owns 21,693 shares of the company’s stock valued at $934,000 after buying an additional 1,552 shares in the last quarter. Wedge Capital Management L L P NC grew its holdings in shares of Ingevity by 2.7% during the second quarter. Wedge Capital Management L L P NC now owns 93,784 shares of the company’s stock valued at $4,041,000 after buying an additional 2,425 shares in the last quarter. Finally, Range Financial Group LLC purchased a new position in shares of Ingevity during the second quarter valued at $1,326,000. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Wall Street Analyst Weigh In

NGVT has been the topic of a number of research analyst reports. Wells Fargo & Company lifted their price target on Ingevity from $38.00 to $48.00 and gave the company an “equal weight” rating in a report on Monday, July 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research note on Saturday. BMO Capital Markets boosted their target price on Ingevity from $62.00 to $68.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Finally, Wall Street Zen upgraded Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Ingevity has an average rating of “Hold” and a consensus target price of $58.00.

Ingevity Price Performance

Shares of NYSE:NGVT opened at $57.14 on Monday. Ingevity Corporation has a fifty-two week low of $28.49 and a fifty-two week high of $60.77. The business has a 50-day moving average of $56.30 and a two-hundred day moving average of $47.01. The stock has a market capitalization of $2.08 billion, a P/E ratio of -9.60 and a beta of 1.40. The company has a debt-to-equity ratio of 10.24, a current ratio of 1.36 and a quick ratio of 0.80.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Friday, March 24th. The company reported $0.78 earnings per share for the quarter. Ingevity had a positive return on equity of 84.92% and a negative net margin of 16.35%.The company had revenue of $336.00 million during the quarter. On average, equities research analysts predict that Ingevity Corporation will post 4.45 EPS for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.